Skip to main content

Letter to the editor

Journal of General Internal Medicine volume 17, page 85 (2002)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Ganz DA, Glynn RJ, Mogun H, Knight EL, Bohn RL, Avorn J. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med. 2000;15:776–81.

    PubMed  Article  CAS  Google Scholar 

  2. Lee HN, Cook DJ, Sarabia A, et al. Inadequacy of intravenous heparin therapy in the initial management of venous thromboembolism. J Gen Intern Med. 1995;10:342–5.

    PubMed  Article  CAS  Google Scholar 

  3. Lindmarker P, Holmstrom M. Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis, a feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin Trial. J Intern Med. 1996;240:395–401.

    PubMed  Article  CAS  Google Scholar 

  4. Bergqvist D. Low molecular weight heparins. J Intern Med. 1996;240:63–72.

    PubMed  Article  CAS  Google Scholar 

  5. Schulman S. Oral anticoagulation in venous thromboembolism: decisions based on more than mere feelings. J Intern Med. 1999;245:399–403.

    PubMed  Article  CAS  Google Scholar 

  6. Luomanmaki K, Grankvist S, Hallert C, et al. A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis. J Intern Med. 1996;240:85–92.

    PubMed  Article  CAS  Google Scholar 

  7. Wells PS, Hirsh J, Anderson DR, et al. A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med. 1998;243:15–23.

    PubMed  Article  CAS  Google Scholar 

  8. Nielsen HK, Husted SE, Krusell LR, Fasting H, Charles P, Hansen HH. Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation. J Intern Med. 1994;235:457–61.

    PubMed  CAS  Article  Google Scholar 

  9. Nielsen HK, Husted SE, Krusell LR, et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thromb Res. 1994;73:215–26.

    PubMed  Article  CAS  Google Scholar 

Download references

Authors
  1. David K. Cundiff MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

JGIM welcomes your letters and comments. Letters may contain brief commentaries on articles published in the Journal, illustrative case reports, general suggestions for improving the Journal, or other information of interest to readers. Letters to the Editor should not exceed 450 words in length and should be sent to the Editor via e-mail at jgim@jhmi.edu.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cundiff, D.K. Letter to the editor. J GEN INTERN MED 17, 85 (2002). https://doi.org/10.1046/j.1525-1497.2002.11138.x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1046/j.1525-1497.2002.11138.x

Keywords

  • Deep Venous Thrombosis
  • Venous Thromboembolism
  • Oral Anticoagulation
  • Phenylbutazone
  • Dalteparin